These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32932563)

  • 21. Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors.
    Huang K; Xu S; Wang J; Ge L; Xu J; Jia X
    J Ovarian Res; 2023 Feb; 16(1):37. PubMed ID: 36759870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additive value of texture analysis based on breast MRI for distinguishing between benign and malignant non-mass enhancement in premenopausal women.
    Tan Y; Mai H; Huang Z; Zhang L; Li C; Wu S; Huang H; Tang W; Liu Y; Jiang K
    BMC Med Imaging; 2021 Mar; 21(1):48. PubMed ID: 33706695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of Borderline Epithelial Ovarian Tumors from Benign and Malignant Epithelial Ovarian Tumors by MRI Scoring.
    Babaoglu S; Atas AE; Kerimoglu U; Iyisoy MS; Kilinc F
    Curr Med Imaging; 2024; 20():e060623217706. PubMed ID: 37282660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perfusion-based functional magnetic resonance imaging for differentiating serous borderline ovarian tumors from early serous ovarian cancers in a rat model.
    Cai SQ; Li Y; Li YA; Wang L; Zhu J; Zhao SH; Qiang JW
    Acta Radiol; 2021 Jan; 62(1):129-138. PubMed ID: 32276553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of proton MR spectroscopy in the differentiation of borderline from malignant epithelial ovarian tumors: A preliminary study.
    Ma FH; Li YA; Liu J; Li HM; Zhang GF; Qiang JW
    J Magn Reson Imaging; 2019 Jun; 49(6):1684-1693. PubMed ID: 30353967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The application value of two-dimensional ultrasound combined with contrast-enhanced ultrasound in the differential diagnosis of benign, borderline, and malignant ovarian epithelial tumors.
    Wang R; Liu H; Tang J; Geng J
    J Ovarian Res; 2024 Sep; 17(1):191. PubMed ID: 39342318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tubo-Ovarian Abscess (with/without Pseudotumor Area) Mimicking Ovarian Malignancy: Role of Diffusion-Weighted MR Imaging with Apparent Diffusion Coefficient Values.
    Wang T; Li W; Wu X; Yin B; Chu C; Ding M; Cui Y
    PLoS One; 2016; 11(2):e0149318. PubMed ID: 26894926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminating Between Benign and Malignant Solid Ovarian Tumors Based on Clinical and Radiomic Features of MRI.
    Zheng Y; Wang H; Li Q; Sun H; Guo L
    Acad Radiol; 2023 May; 30(5):814-822. PubMed ID: 35810066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computed tomography-based texture assessment for the differentiation of benign, borderline, and early-stage malignant ovarian neoplasms.
    He Z; Chen J; Yang F; Pan X; Liu C
    J Int Med Res; 2023 Jan; 51(1):3000605221150139. PubMed ID: 36688472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study.
    Zhang H; Mao Y; Chen X; Wu G; Liu X; Zhang P; Bai Y; Lu P; Yao W; Wang Y; Yu J; Zhang G
    Eur Radiol; 2019 Jul; 29(7):3358-3371. PubMed ID: 30963272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR imaging of epithelial ovarian cancer: a combined model to predict histologic subtypes.
    Qian L; Ren J; Liu A; Gao Y; Hao F; Zhao L; Wu H; Niu G
    Eur Radiol; 2020 Nov; 30(11):5815-5825. PubMed ID: 32535738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer.
    Wang Y; Yu B; Zhong F; Guo Q; Li K; Hou Y; Lin N
    Magn Reson Imaging; 2019 Jul; 60():76-84. PubMed ID: 30917943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI-based texture analysis for differentiating pediatric craniofacial rhabdomyosarcoma from infantile hemangioma.
    Sarioglu FC; Sarioglu O; Guleryuz H; Ozer E; Ince D; Olgun HN
    Eur Radiol; 2020 Oct; 30(10):5227-5236. PubMed ID: 32382846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour.
    Kurata Y; Kido A; Moribata Y; Kameyama K; Himoto Y; Minamiguchi S; Konishi I; Togashi K
    Eur Radiol; 2017 Apr; 27(4):1695-1703. PubMed ID: 27553934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages.
    Kotowicz B; Fuksiewicz M; Sobiczewski P; Spiewankiewicz B; Jonska-Gmyrek J; Skrzypczak M; Kowalska M
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():141-6. PubMed ID: 26398337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of Fuhrman grade of renal clear cell carcinoma by multimodal MRI radiomics: a retrospective study.
    Pan L; Chen M; Sun J; Jin P; Ding J; Cai P; Chen J; Xing W
    Clin Radiol; 2024 Feb; 79(2):e273-e281. PubMed ID: 38065776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [High-throughput texture analysis in the distinction of single metastatic brain tumors from high-grade gliomas].
    Yin HL; Li DB; Jiang Y; Li SH; Chen Y; Lin GW
    Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):841-846. PubMed ID: 30481936
    [No Abstract]   [Full Text] [Related]  

  • 38. Differential Diagnosis of Solitary Fibrous Tumor/Hemangiopericytoma and Angiomatous Meningioma Using Three-Dimensional Magnetic Resonance Imaging Texture Feature Model.
    Dong J; Yu M; Miao Y; Shen H; Sui Y; Liu Y; Han L; Li X; Lin M; Guo Y; Xie L
    Biomed Res Int; 2020; 2020():5042356. PubMed ID: 33344637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT and MRI findings of type I and type II epithelial ovarian cancer.
    Liu D; Zhang L; Indima N; Peng K; Li Q; Hua T; Tang G
    Eur J Radiol; 2017 May; 90():225-233. PubMed ID: 28583639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Texture analysis of magnetic resonance image to differentiate benign from malignant myxoid soft tissue tumors: A retrospective comparative study.
    Chang H; Kang Y; Ahn JM; Lee E; Lee JW; Kang HS
    PLoS One; 2022; 17(5):e0267569. PubMed ID: 35587928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.